La Jolla Pharmaceutical Company (LJPC)

7.15
NASDAQ
Prev Close 7.15
Day Low/High 0.00 / 0.00
52 Wk Low/High 5.01 / 38.39
Exchange NASDAQ
Shares Outstanding 27.08B
Market Cap 193.59M
Div & Yield N.A. (N.A)

Latest News

Interesting LJPC Put And Call Options For September 20th

Interesting LJPC Put And Call Options For September 20th

Investors in La Jolla Pharmaceutical Co. saw new options begin trading this week, for the September 20th expiration.

La Jolla Stock Plummets 44% After Disappointing Drug Sales Projections

La Jolla Stock Plummets 44% After Disappointing Drug Sales Projections

La Jolla Pharmaceutical Co.'s share price fell to $5.88 by 1:42 pm, down from its close of $10.52 on Friday, after the company said it expects sales of low blood pressure drug Giapreza to hit $24-$28 million in 2019, roughly half of what analysts had projected.

Relative Strength Alert For La Jolla Pharmaceutical

Relative Strength Alert For La Jolla Pharmaceutical

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

LJPC: Insiders Vs. Shorts

LJPC: Insiders Vs. Shorts

The most recent short interest data was recently released for the 11/15/2018 settlement date, and La Jolla Pharmaceutical Co. is one of the most shorted stocks of the Russell 3000, based on 26.03 "days to cover" versus the median component at 4.41.

La Jolla Pharmaceutical Enters Oversold Territory (LJPC)

La Jolla Pharmaceutical Enters Oversold Territory (LJPC)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

La Jolla Pharmaceutical Becomes Oversold (LJPC)

La Jolla Pharmaceutical Becomes Oversold (LJPC)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

La Jolla Pharmaceutical Enters Oversold Territory (LJPC)

La Jolla Pharmaceutical Enters Oversold Territory (LJPC)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

First Week Of LJPC October 19th Options Trading

First Week Of LJPC October 19th Options Trading

Investors in La Jolla Pharmaceutical Co. saw new options begin trading this week, for the October 19th expiration.

La Jolla Pharmaceutical Is Now Oversold (LJPC)

La Jolla Pharmaceutical Is Now Oversold (LJPC)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

La Jolla Pharmaceutical Breaks Above 200-Day Moving Average - Bullish For LJPC

La Jolla Pharmaceutical Breaks Above 200-Day Moving Average - Bullish For LJPC

In trading on Friday, shares of La Jolla Pharmaceutical Co. crossed above their 200 day moving average of $31.77, changing hands as high as $32.33 per share.

La Jolla Pharmaceutical Enters Oversold Territory

La Jolla Pharmaceutical Enters Oversold Territory

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

La Jolla Pharmaceutical (LJPC) Shares Cross Above 200 DMA

In trading on Wednesday, shares of La Jolla Pharmaceutical Co. crossed above their 200 day moving average of $32.10, changing hands as high as $32.32 per share.

Interesting LJPC Put And Call Options For May 18th

Interesting LJPC Put And Call Options For May 18th

Investors in La Jolla Pharmaceutical Co. saw new options become available this week, for the May 18th expiration.

La Jolla Pharmaceutical (LJPC) Shares Cross Above 200 DMA

La Jolla Pharmaceutical (LJPC) Shares Cross Above 200 DMA

In trading on Thursday, shares of La Jolla Pharmaceutical Co. crossed above their 200 day moving average of $32.07, changing hands as high as $32.68 per share.

GIAPREZA™ (angiotensin II) Significantly Improved Survival Of Patients With High APACHE II Scores In ATHOS-3 Study

GIAPREZA™ (angiotensin II) Significantly Improved Survival Of Patients With High APACHE II Scores In ATHOS-3 Study

Analysis to Be Presented in Oral Session at the Society of Critical Care Medicine's 47th Critical Care Congress

First Week of LJPC February 16th Options Trading

First Week of LJPC February 16th Options Trading

Investors in La Jolla Pharmaceutical Co. saw new options become available this week, for the February 16th expiration.

Relative Strength Alert For La Jolla Pharmaceutical

Relative Strength Alert For La Jolla Pharmaceutical

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Notable Friday Option Activity: LJPC, BANC, SIEN

Notable Friday Option Activity: LJPC, BANC, SIEN

Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in La Jolla Pharmaceutical Co. , where a total of 2,618 contracts have traded so far, representing approximately 261,800 underlying shares.

La Jolla Pharmaceutical Company Announces Financial Results For The Three And Nine Months Ended September 30, 2017 And Recent Corporate Progress

La Jolla Pharmaceutical Company Announces Financial Results For The Three And Nine Months Ended September 30, 2017 And Recent Corporate Progress

La Jolla Pharmaceutical Company (NASDAQ: LJPC) (the Company or La Jolla), a leader in the development of innovative therapies intended to significantly improve outcomes in patients suffering from life-threatening...

TheStreet Quant Rating: D- (Sell)